Internal Medicine, Endocrinology, Diabetes, & Metabolism · Williamsville, NY
NPI
1750343141
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
5
Medicare group memberships
Hospitals
3
Hospital affiliations
100 College Pkwy Ste 260
Williamsville, NY, 14221
Phone (716) 635-0688
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
300 services
Medicare patients, 2024
132
Average age 72
Drug cost, 2024
$3.8M
4,863 prescriptions
Company payments, 2025
$3,675
From 35 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Howard A Lippes was code 99214 (office e&m - established), 161 times for 97 patients. In total Howard A Lippes billed 300 services in 17 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-06-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 161 | 97 | $87.15 | $14K |
| 95251 Test - Miscellaneous | Office | 72 | 44 | $22.63 | $1,630 |
| 99213 Office E&M - Established | Office | 14 | 13 | $38.82 | $543 |
By year: 2022 $18K for 283 services; 2023 $32K for 519 services; 2024 $19K for 300 services.
Medicare prescription drug claims, 2024
In 2024, the drug Howard A Lippes prescribed most often to Medicare patients was Ozempic (Semaglutide), with 360 prescriptions and refills. In total Howard A Lippes wrote 4,863 Medicare prescriptions that cost $3.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 360 | 623 | 90 | $595K |
| Levothyroxine Sodium Generic | 346 | 1,016 | 98 | $7,397 |
| Rosuvastatin Calcium Generic | 343 | 988 | 103 | $6,611 |
| Mounjaro Tirzepatide | 307 | 530 | 78 | $551K |
| Atorvastatin Calcium Generic | 211 | 595 | 58 | $3,414 |
| Jardiance Empagliflozin | 189 | 439 | 51 | $249K |
| Methimazole Generic | 126 | 308 | 35 | $2,638 |
| Metformin Hcl Er Metformin Hcl | 107 | 303 | 34 | $2,539 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 106 | 223 | 33 | $175K |
| Ezetimibe Generic | 103 | 285 | 35 | $3,477 |
| Lisinopril Generic | 100 | 300 | 32 | $1,019 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 94 | 177 | 18 | $118K |
| Metformin Hcl Generic | 93 | 277 | 28 | $1,792 |
| Humalog Kwikpen U-100 Insulin Lispro | 93 | 204 | 31 | $36K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 88 | 185 | 27 | $8,509 |
Brand drugs: 2,192 claims; generic drugs: 2,286 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Howard A Lippes $3,675 ($3,675 in general payments such as food, travel and fees) from 35 companies. The largest payer was Amgen Inc. with $481.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 21 | $481 |
| Lilly USA, LLC LLY | 11 | $280 |
| Abbott Laboratories ABT | 6 | $241 |
| Mannkind Corporation MNKD | 11 | $240 |
| Ascendis Pharma Endocrinology Inc ASND | 8 | $215 |
| Insulet Corporation PODD | 9 | $177 |
| Corcept Therapeutics CORT | 11 | $172 |
| Novo Nordisk Inc NVO | 13 | $168 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $167 |
| Abbvie Inc. ABBV | 9 | $159 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.